Health Investment Partners

Health Investment Partners

Health Investment Partners operates as a specialized private equity firm focused on the European healthcare sector. The firm invests in companies developing medical devices, digital health platforms, and healthcare services—areas where commercial adoption often lags behind clinical validation. Its base in Amsterdam reflects the broader concentration of health-tech investment expertise in the Netherlands. The firm pursues a growth-equity strategy, providing expansion capital to companies that have already navigated early regulatory hurdles. It engages across both early-stage and late-stage investments, covering start-up, expansion, and growth phases. This approach bridges the gap where traditional venture capital retreats after initial clinical de-risking and where generalist buyout funds lack the domain knowledge to underwrite healthcare-specific reimbursement and adoption risks. The investment footprint extends across Western and Northern Europe. Team size and total assets under management are not publicly disclosed. No adjacent vehicles—such as philanthropic foundations, credit arms, or real-asset subsidiaries—are known. In the absence of openly published records, the firm's precise operational scale and partnership structure remain opaque. A structural differentiator for the firm is its thesis-driven, single-sector concentration within European lower-middle-market healthcare. By operating without a broader multi-sector mandate, the firm can focus underwriting resources on reimbursement pathways, clinical adoption curves, and regulatory moats—factors that generalist investors often misprice. This narrow aperture, however, also makes deployment pace dependent on the irregular cadence of health-tech exits in Europe.